CORVUS PHARMACEUTICALS INC (CRVS) Stock Cash Flow
NASDAQ:CRVS - Nasdaq - US2210151005 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -41.40M | -62.29M | -27.03M | -41.31M | -43.24M | |||
| Depreciation Amortization | 84.00K | 85.00K | 151.00K | 370.00K | 460.00K | |||
| Change In Working Capital | -1.71M | -1.65M | -3.59M | 1.41M | -3.24M | |||
| Other non cash items | 14.50M | 38.43M | 6.54M | 12.51M | 9.30M | |||
| OPERATING CASH FLOW | -28.53M | -25.42M | -23.93M | -27.02M | -36.72M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | -34.00K | -270.00K | -10.00K | |||
| Other Investing Activity | -23.20M | -27.48M | 15.57M | -23.01M | 21.57M | |||
| INVESTING CASH FLOW | -23.23M | -27.48M | 15.54M | -23.28M | 21.56M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | N/A | 49.03M | 7.86M | 0.00 | 62.16M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 49.31M | 49.03M | 7.86M | 0.00 | 62.16M | |||
| CHANGE IN CASH | -2.46M | -3.88M | -539.00K | -50.30M | 47.00M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -28.53M | -25.42M | -23.93M | -27.02M | -36.72M | |||
| Capital Expenditure | N/A | N/A | -34.00K | -270.00K | -10.00K | |||
| FREE CASH FLOW | -28.57M | -25.42M | -23.97M | -27.29M | -36.73M | |||
All data in USD